Source: Cancer Immunology, Immunotherapy. Unidade: ICB
Subjects: MICROBIOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, FÁRMACOS IMUNOSSUPRESSORES, IMUNOTERAPIA, PAPILLOMAVIRUS, GLICOPROTEÍNAS, ONCOPROTEÍNAS, LINFÓCITOS T
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jamile Ramos da et al. Expression of a soluble IL-10 receptor enhances the therapeutic effects of a papillomavirus-associated antitumor vaccine in a murine model. Cancer Immunology, Immunotherapy, v. 68, n. 5, p. 753-763, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00262-018-02297-2. Acesso em: 14 jun. 2024.APA
Silva, J. R. da, Sales, N. S., Silva, M. de O., Aps, L. R. de M. M., Moreno, A. C. R., Rodrigues, E. G., et al. (2019). Expression of a soluble IL-10 receptor enhances the therapeutic effects of a papillomavirus-associated antitumor vaccine in a murine model. Cancer Immunology, Immunotherapy, 68( 5), 753-763. doi:10.1007/s00262-018-02297-2NLM
Silva JR da, Sales NS, Silva M de O, Aps LR de MM, Moreno ACR, Rodrigues EG, Ferreira LC de S, Diniz M de O. Expression of a soluble IL-10 receptor enhances the therapeutic effects of a papillomavirus-associated antitumor vaccine in a murine model [Internet]. Cancer Immunology, Immunotherapy. 2019 ; 68( 5): 753-763.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1007/s00262-018-02297-2Vancouver
Silva JR da, Sales NS, Silva M de O, Aps LR de MM, Moreno ACR, Rodrigues EG, Ferreira LC de S, Diniz M de O. Expression of a soluble IL-10 receptor enhances the therapeutic effects of a papillomavirus-associated antitumor vaccine in a murine model [Internet]. Cancer Immunology, Immunotherapy. 2019 ; 68( 5): 753-763.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1007/s00262-018-02297-2